GD2-specific Chimeric Antigen Receptor-modified T Cells for the treatment of Refractory and/or Recurrent Neuroblastoma in Pediatric PatientsLihua Yu, Lihua Yang, Guanmei Zhang et al.|Research Square|2021Cited by 7